Claude Guillou

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Simultaneous Determination

Gas Chromatography

High Resolution Mass Spectrometry

Emergency Department

Top Venues

Drug testing and analysis

This page only lists publications with an associated author ORCID identifier.

Publications

Caitlyn Norman, Kristin Webling, Oleksandra Kyslychenko, Robert Reid, Alex J Krotulski, Ryan Farrell, Marie H Deventer, Huiling Liu, Matthew J Connolly, Claude Guillou, Inge M J Vinckier, Barry K Logan, Niamh Nic Daéid, Craig McKenzie, Christophe Pol Stove, Henrik Green
Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5-bromo-indazole-3-carboxamide synthetic cannabinoid receptor agonists. Drug testing and analysis (2023)
Caitlyn Norman, Marie H Deventer, Olivia Dremann, Robert Reid, Katleen Van Uytfanghe, Claude Guillou, Inge M J Vinckier, Niamh Nic Daéid, Alex J Krotulski, Christophe Pol Stove
In vitro cannabinoid receptor activity, metabolism, and detection in seized samples of CH-PIATA, a new indole-3-acetamide synthetic cannabinoid. Drug testing and analysis (2023)
Marie H Deventer, Katleen Van Uytfanghe, Inge M J Vinckier, Fabiano Reniero, Claude Guillou, Christophe Pol Stove
A new cannabinoid receptor 1 selective agonist evading the 2021 "China ban": ADB-FUBIATA. Drug testing and analysis 14 (9) (2022)
Marie H Deventer, Katleen Van Uytfanghe, Inge M J Vinckier, Fabiano Reniero, Claude Guillou, Christophe Pol Stove
Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists. Drug testing and analysis 14 (9) (2022)